|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The early retirement plans of women and men: an empirical application显示文摘 | Alphonse G. Holtmann Steven G. Ullmann Paul Fronstin Charles F. Longino | 1994 | Applied Economics1994，，6： | 1 |
| 2 | Review article: associations between H elicobacter pylori and obesity ‐ an ecological study显示文摘 | N. Lender N. J. Talley P. Enck S. Haag S. Zipfel M. Morrison G. J. Holtmann | 2014 | Aliment Pharmacol Ther2014，，1： | 1 |
| 3 | Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission显示文摘 | A. Lucas P.M. Cobelens A. Kavelaars C.J. Heijnen G. Holtmann S. Haag G. Gerken J. Langhorst G.J. Dobos M. Schedlowski S. Elsenbruch | 2005 | Journal of Neuroimmunology2005，，1： | 1 |
| 4 | 伊托必利治疗功能性消化不良:一项安慰剂对照试验显示文摘BACKGROUND:The treatment of patients with functional dyspepsia remains unsatisfactory.We assessed the efficacy of itopride,a dopamine D2 antagonist with acetylcholinesterase effects,in patients with functional dyspepsia.METHODS:Patients with functional dyspepsia were randomly assigned to receive either itopride(50,100,or 200 mg three times daily)or placebo.After eight weeks of treatment,three primary efficacy end points were analyzed:the change from baseline in the severity of symptoms of functional dyspepsia(as assessed by the Leeds Dyspepsia Questionnaire),patients’global assessment of efficacy(the proportion of patients without symptoms or with marked improvement),and the severity of pain or fullness as rated on a five-grade scale.RESULTS:We randomly assigned 554 patients;523 had outcome data and could be included in the analyses.After eight weeks,41 percent of the patients receiving placebo were symptom-free or had marked improvement,as compared with 57 percent,59 percent,and 64 percent receiving itopride at a dose of 50,100,or 200 mg three times daily,respectively(P < 0.05 for all comparisons between placebo and itopride).Although the symptom score improved significantly in all four groups,an overall analysis revealed that itopride was significantly superior to placebo,with the greatest symptom-score improvement in the 100 and 200 mg groups(-6.24 and-6.27,vs.-4.50 in the placebo group;P = 0.05).Analysis of the combined end point of pain and fullness showed that itopride yielded a greater rate of response than placebo(73 percent vs.63 percent,P = 0.04).CONCLUSIONS:Itopride significantly improves symptoms in patients with functional dyspepsia. | Holtmann G. Talley N.J. Liebregts T. 王晓君 | 2006 | 世界核心医学期刊文摘(胃肠病学分册)2006，2，9： | 1 |
| 5 | Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility显示文摘 | G. Holtmann MD M. V. Singer MD R. Kriebel PhD K. H. St?cker PhD H. Goebell MD | 1989 | Digestive Diseases and Sciences1989，，11： | 1 |
| 6 | A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease显示文摘 | C. Sack V.A. Phan R. Grafton G. Holtmann D.R. van Langenberg K. Brett M. Clark J.M. Andrews | 2011 | Journal of Crohn’s and Colitis2011，，3： | 1 |
| 7 | A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease显示文摘 | C. Sack V.A. Phan R. Grafton G. Holtmann D.R. van Langenberg K. Brett M. Clark J.M. Andrews | 2011 | Journal of Crohn’s and Colitis2011，，3： | 1 |
| 8 | 临床表现和人格因素作为功能性消化不良患者的疗效预测指标:一项随机、双盲、安慰剂对照的交叉试验 | Holtmann G. Kutscher S.-U. Haag S. 郝筱倩 | 2005 | 世界核心医学期刊文摘(胃肠病学分册)2005，0，1： | 0 |
| 9 | 在咨询者与未咨询者中,功能性消化不良和肠易激综合征的症状表型与胃排空紊乱及营养素激发应答的关系 | Haag S. Talley N.J. Holtmann G. 杨瑗 | 2005 | 世界核心医学期刊文摘(胃肠病学分册)2005，0，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员